{"id":23085,"date":"2023-07-20T13:39:20","date_gmt":"2023-07-20T20:39:20","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23085"},"modified":"2025-06-04T15:31:26","modified_gmt":"2025-06-04T22:31:26","slug":"a-comprehensive-guide-to-ivig-therapy-for-ms","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/","title":{"rendered":"Una gu\u00eda completa sobre la terapia con IgIV para la EM"},"content":{"rendered":"<p>La esclerosis m\u00faltiple (EM) es una enfermedad debilitante que afecta a casi un mill\u00f3n de estadounidenses. Los tratamientos para la EM sol\u00edan centrarse \u00fanicamente en la prevenci\u00f3n de complicaciones. Sin embargo, gracias a avances significativos en la medicina, como el uso de inmunoglobulina intravenosa (IVIG) para la EM, los pacientes ahora disfrutan de una mejor calidad de vida.<\/p>\n\n\n\n<p>La IgIV es un tipo de tratamiento que proporciona anticuerpos a los pacientes, los cuales ayudan a combatir la infecci\u00f3n y, al mismo tiempo, reducen el riesgo de una reca\u00edda de la EM. Puede ser eficaz para ayudarle a controlar sus s\u00edntomas y a vivir mejor con EM.<\/p>\n\n\n\n<p>Si acaba de enterarse de esta terapia, quiz\u00e1s sea el momento de informarse y hablar sobre su potencial con su m\u00e9dico. Aqu\u00ed encontrar\u00e1 todo lo que necesita saber. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/what-to-expect-during-your-ivig-infusion-treatment\/\">Tratamiento con IgIV<\/a> para la EM.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#What_is_MS\" >\u00bfQu\u00e9 es la EM?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#Symptoms_of_MS\" >S\u00edntomas de la EM<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#MS_Diagnostic_Tests\" >Pruebas de diagn\u00f3stico de EM<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#MS_%E2%80%93_Forms_and_Treatments\" >Esclerosis M\u00faltiple: formas y tratamientos<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#What_is_IVIG_Treatment_for_MS\" >\u00bfQu\u00e9 es el tratamiento con IgIV para la EM?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#How_Does_IVIG_Work\" >\u00bfC\u00f3mo funciona la IgIV?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#How_Can_IVIG_Treatment_Help_With_MS\" >\u00bfC\u00f3mo puede ayudar el tratamiento con IgIV en la EM?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#IVIG_for_CIS\" >IgIV para el CIS<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#IVIG_for_RRMS\" >IgIV para EMRR<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#IVIG_for_PPMS_and_SPMS\" >IgIV para EMPP y EMSP<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#How_Effective_is_IVIG_Treatment_for_MS\" >\u00bfQu\u00e9 tan efectivo es el tratamiento con IgIV para la EM?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#Side_Effects_of_IVIG\" >Efectos secundarios de la IgIV<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#How_Does_IVIG_Treatment_for_MS_Go\" >\u00bfC\u00f3mo va el tratamiento con IgIV para la EM?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#How_Long_Does_IVIG_Take_to_Work\" >\u00bfCu\u00e1nto tiempo tarda en hacer efecto la IgIV?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#How_Much_Does_IVIG_for_MS_Cost\" >\u00bfCu\u00e1nto cuesta la IgIV para la EM?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#Insurance_and_Financial_Aid_for_IVIG\" >Seguro y ayuda financiera para la IgIV<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#Receive_At-Home_IVIG_for_MS_from_AmeriPharma%C2%AE_Specialty_Pharmacy\" >Reciba IgIV en casa para la EM de la farmacia especializada AmeriPharma\u00ae<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-ms\"><span class=\"ez-toc-section\" id=\"What_is_MS\"><\/span>\u00bfQu\u00e9 es la EM?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Antes de conocer el potencial de la IgIV para la EM, es necesario comprender la enfermedad en s\u00ed.<\/p>\n\n\n\n<p>La esclerosis m\u00faltiple es la enfermedad m\u00e1s com\u00fan. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/guide-to-demyelinating-disease\/\">enfermedad desmielinizante<\/a> en los EE.UU. En esta enfermedad autoinmune, el sistema inmunitario del cuerpo ataca el sistema nervioso central, que incluye el cerebro y la m\u00e9dula espinal.<\/p>\n\n\n\n<p>Cada nervio del cuerpo est\u00e1 compuesto por varias c\u00e9lulas (neuronas) recubiertas de un tejido graso llamado mielina. La mielina ayuda a proteger la neurona y a enviar mensajes r\u00e1pidos hacia y desde el cerebro. En la EM, el cuerpo confunde la mielina con un componente extra\u00f1o y comienza a atacarla. Esto la da\u00f1a, causando cicatrices o placas en su lugar. Al reducirse la mielina, los mensajes no se transmiten con la misma rapidez ni eficiencia, y la comunicaci\u00f3n se interrumpe. En algunos casos, la neurona puede sufrir da\u00f1os, lo que aumenta la discapacidad.<\/p>\n\n\n\n<p>La EM es m\u00e1s com\u00fan en mujeres que en hombres y se presenta entre los 20 y los 50 a\u00f1os. Puede afectar a personas de cualquier etnia, pero es m\u00e1s frecuente en personas cauc\u00e1sicas del norte de Europa.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-symptoms-of-ms\"><span class=\"ez-toc-section\" id=\"Symptoms_of_MS\"><\/span>S\u00edntomas de la EM<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La IgIV para la EM se centra en mejorar los s\u00edntomas de la enfermedad. Dado que esta afecci\u00f3n afecta el sistema nervioso central, puede afectar la movilidad y el habla. Los s\u00edntomas m\u00e1s comunes de la EM son:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fatiga<\/li>\n\n\n\n<li>Problemas de visi\u00f3n<\/li>\n\n\n\n<li>Problemas de movilidad<\/li>\n\n\n\n<li>Sensaci\u00f3n de opresi\u00f3n alrededor del torso (abrazo EM)<\/li>\n\n\n\n<li>Disfunci\u00f3n sexual<\/li>\n\n\n\n<li>Hormigueo y entumecimiento<\/li>\n\n\n\n<li>Depresi\u00f3n y ansiedad<\/li>\n\n\n\n<li>Problemas de intestino y vejiga<\/li>\n\n\n\n<li>Espasmos musculares y debilidad<\/li>\n\n\n\n<li>Problemas cognitivos como dificultad para concentrarse<\/li>\n\n\n\n<li>Dolor y picaz\u00f3n<\/li>\n<\/ul>\n\n\n\n<p>El tratamiento con IgIV para la EM se muestra prometedor para aliviar estos s\u00edntomas, que pueden diferir en gravedad para cada persona.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ms-diagnostic-tests\"><span class=\"ez-toc-section\" id=\"MS_Diagnostic_Tests\"><\/span>Pruebas de diagn\u00f3stico de EM<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Los signos iniciales de la EM pueden ser similares a los de otras enfermedades, y no existe una prueba \u00fanica para diagnosticarla. Antes de recomendar la IgIV para la EM, los m\u00e9dicos deben descartar otras afecciones mediante las siguientes pruebas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Una resonancia magn\u00e9tica del cerebro y la m\u00e9dula espinal en busca de placas.<\/li>\n\n\n\n<li>An\u00e1lisis de sangre para detectar otras posibles causas de los s\u00edntomas.<\/li>\n\n\n\n<li>Pruebas de punci\u00f3n lumbar o punci\u00f3n raqu\u00eddea en busca de prote\u00ednas espec\u00edficas<\/li>\n\n\n\n<li>Pruebas de potenciales evocados que miden el tiempo de respuesta del cerebro a la estimulaci\u00f3n nerviosa.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ms-forms-and-treatments\"><span class=\"ez-toc-section\" id=\"MS_%E2%80%93_Forms_and_Treatments\"><\/span>Esclerosis M\u00faltiple: formas y tratamientos<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La EM se clasifica de la siguiente manera seg\u00fan sus cuatro cursos de enfermedad.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-1-cis\">1. CEI<\/h4>\n\n\n\n<p>El s\u00edndrome cl\u00ednicamente aislado (SCA) es el episodio inicial de s\u00edntomas que dura 24 horas o m\u00e1s. En esta etapa, s\u00edntomas como problemas visuales, hormigueo y entumecimiento se deben a la inflamaci\u00f3n o desmielinizaci\u00f3n del sistema nervioso central. Si bien el SCA es t\u00edpico de la EM, no todas las personas que lo padecen desarrollan EM.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-2-rrms\">2. EMRR<\/h4>\n\n\n\n<p>La EM remitente-recurrente (EMRR) es el segundo curso de EM para el cual los m\u00e9dicos prescriben IgIV. La EMRR es el tipo m\u00e1s com\u00fan de EM, donde los per\u00edodos de recuperaci\u00f3n parcial o completa (remisi\u00f3n) siguen a per\u00edodos de aumento de los s\u00edntomas (reca\u00eddas).<\/p>\n\n\n\n<p>Aproximadamente el 85% de los pacientes tienen EMRR cuando los m\u00e9dicos les diagnostican EM. La mayor\u00eda de los tratamientos aprobados por la FDA para la EM, incluyendo <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/tysabri-natalizumab\/\">Tysabri<\/a> y <a href=\"https:\/\/ameripharmaspecialty.com\/es\/other-health-conditions\/glatiramer-acetate-copaxone-glatopa\/\">acetato de Glatiramer<\/a>, apuntar a esta etapa de la EM.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-3-ppms\">3. PPMS<\/h4>\n\n\n\n<p>La EM primaria progresiva (EMPP) es la forma progresiva de la enfermedad, que afecta entre el 10% y el 15% de las personas en el momento del diagn\u00f3stico. El tratamiento con IgIV para la EM puede no ser tan eficaz en esta etapa como en la EMRR.<\/p>\n\n\n\n<p>Durante la EMPP no hay brotes, pero los s\u00edntomas y la disminuci\u00f3n de la funci\u00f3n neurol\u00f3gica progresan de forma constante tan pronto como aparecen los s\u00edntomas. La velocidad de progresi\u00f3n var\u00eda seg\u00fan la persona.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"h-4-spms\">4. SPMS<\/h4>\n\n\n\n<p>La EM secundaria progresiva (EMSP) se desarrolla tras un curso inicial de EMRR. La diferencia radica en que, como en la EMRR, no hay recuperaci\u00f3n tras los brotes.<\/p>\n\n\n\n<p>A partir de este punto, la enfermedad solo progresa. Por lo tanto, al igual que en la EMPP, la EM para la IgIV no es tan eficaz a menos que se utilice para el brote inicial de la enfermedad. La diferencia entre la EMSP y la EMPP radica en que la EMSP no es un diagn\u00f3stico inicial, mientras que la EMPP s\u00ed lo es.<\/p>\n\n\n\n<p>Los tratamientos actuales para la EM, centrados en la EMRR, no son del todo eficaces para controlar estas formas progresivas de la enfermedad. Sin embargo, han surgido terapias m\u00e1s prometedoras, como la inmunoglobulina intravenosa (IVIG), que pueden permitir a las personas con EM llevar una vida m\u00e1s saludable.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-is-ivig-treatment-for-ms\"><span class=\"ez-toc-section\" id=\"What_is_IVIG_Treatment_for_MS\"><\/span>\u00bfQu\u00e9 es el tratamiento con IgIV para la EM?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"681\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1.jpg\" alt=\"IV drip\" class=\"wp-image-23257\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1.jpg 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1-768x511.jpg 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1-280x186.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1-370x246.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-drip-1-960x638.jpg 960w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p><\/p>\n\n\n\n<p>La inmunoglobulina intravenosa, o IgIV, consiste en una mezcla de anticuerpos obtenidos de donantes sanos. Los anticuerpos (inmunoglobulinas) presentes en las soluciones de IgIV para pacientes con EM son prote\u00ednas espec\u00edficas que fortalecen el sistema inmunitario.<\/p>\n\n\n\n<p>Adem\u00e1s de la esclerosis m\u00faltiple, los m\u00e9dicos tambi\u00e9n recetan IgIV para diversas enfermedades e infecciones autoinmunes, como el s\u00edndrome de Guillain-Barr\u00e9 (SGB), el VIH, la inmunodeficiencia primaria y otras. Puedes ver esto. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig\/\/ivig\/\">gu\u00eda completa de IgIV<\/a> Para obtener m\u00e1s informaci\u00f3n sobre el tratamiento.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-ivig-work\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Work\"><\/span>\u00bfC\u00f3mo funciona la IgIV?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Se desconoce el mecanismo de acci\u00f3n preciso de la IgIV. Sin embargo, los cient\u00edficos suponen que, una vez que los anticuerpos entran en el organismo, act\u00faan sobre ciertas partes del sistema inmunitario, estimulando ciertas c\u00e9lulas y suprimiendo otras.<\/p>\n\n\n\n<p>Las partes suprimidas son las que producen anticuerpos en enfermedades autoinmunes e inflamatorias. Los componentes de la IgIV inhiben la actividad de las c\u00e9lulas B y T, impidi\u00e9ndoles producir autoanticuerpos que da\u00f1an los tejidos o las neuronas, como en la esclerosis m\u00faltiple (EM).<\/p>\n\n\n\n<p>En general, el objetivo final de la IgIV para la EM y otras enfermedades complejas es normalizar el sistema inmunol\u00f3gico, disminuir la duraci\u00f3n de las reca\u00eddas y alargar el per\u00edodo de tiempo entre ellas.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-can-ivig-treatment-help-with-ms\"><span class=\"ez-toc-section\" id=\"How_Can_IVIG_Treatment_Help_With_MS\"><\/span>\u00bfC\u00f3mo puede ayudar el tratamiento con IgIV en la EM?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El mecanismo del tratamiento con IgIV para la EM se basa en los efectos positivos de la soluci\u00f3n de infusi\u00f3n sobre el sistema inmunol\u00f3gico.<\/p>\n\n\n\n<p>Los estudios sugieren que la IgIV est\u00e1 mostrando potencial en las siguientes \u00e1reas:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Manejo de reca\u00eddas agudas y prevenci\u00f3n de nuevas<\/li>\n\n\n\n<li>Prevenci\u00f3n de reca\u00eddas de EM en el embarazo posparto<\/li>\n\n\n\n<li>Ayudando a las personas que no pueden tolerar los medicamentos tradicionales para la EM<\/li>\n\n\n\n<li>Tratamiento de personas que recibieron un tratamiento de primera l\u00ednea sin \u00e9xito para la EMRR<\/li>\n\n\n\n<li>Promover la remielinizaci\u00f3n de los nervios en el sistema nervioso central y ralentizar la progresi\u00f3n de la enfermedad.<\/li>\n<\/ul>\n\n\n\n<p>Aqu\u00ed te explicamos c\u00f3mo <a href=\"https:\/\/ameripharmaspecialty.com\/es\/conditions-treatments\/immune-globulin-ig\/\">Terapia con IgIV<\/a> Puede afectar diferentes cursos de la enfermedad.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ivig-for-cis\"><span class=\"ez-toc-section\" id=\"IVIG_for_CIS\"><\/span>IgIV para el CIS<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16998754\/\">Estudios<\/a> se\u00f1alan la eficacia de la IgIV para esta etapa de la EM. La IgIV puede ser la opci\u00f3n terap\u00e9utica ideal para el CIS, especialmente cuando otras formas de inmunoterapia no est\u00e1n disponibles o no tuvieron \u00e9xito.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ivig-for-rrms\"><span class=\"ez-toc-section\" id=\"IVIG_for_RRMS\"><\/span>IgIV para EMRR<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18645164\/\">Ensayos cl\u00ednicos<\/a> Demuestran los efectos positivos de los tratamientos con IgIV en la EMRR. En estos ensayos, la IgIV ralentiz\u00f3 la formaci\u00f3n de lesiones cerebrales y prolong\u00f3 el per\u00edodo entre reca\u00eddas.<\/p>\n\n\n\n<p>La IgIV tambi\u00e9n puede prevenir las reca\u00eddas en <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29858532\/\">embarazo posparto<\/a>Este efecto de la IgIV la convierte en un tratamiento ideal para mujeres embarazadas y en per\u00edodo de lactancia, ya que no pueden tomar medicamentos inmunomoduladores.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-ivig-for-ppms-and-spms\"><span class=\"ez-toc-section\" id=\"IVIG_for_PPMS_and_SPMS\"><\/span>IgIV para EMPP y EMSP<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>La IgIV para la EM no es tan eficaz en las etapas progresivas. Sin embargo, algunos estudios preliminares... <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17623736\/\">estudios<\/a> Destacar su eficacia para ayudar a las personas con EMPP a controlar sus s\u00edntomas.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-effective-is-ivig-treatment-for-ms\"><span class=\"ez-toc-section\" id=\"How_Effective_is_IVIG_Treatment_for_MS\"><\/span>\u00bfQu\u00e9 tan efectivo es el tratamiento con IgIV para la EM?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La eficacia de la IgIV para la EM no se conoce por completo. La mayor\u00eda de los profesionales de la salud la basan en sus efectos positivos en afecciones como la miastenia gravis y... <a href=\"https:\/\/ameripharmaspecialty.com\/es\/guillain-barre-syndrome\/guillain-barre-syndrome-vs-multiple-sclerosis\/\">S\u00edndrome de Guillain-Barr\u00e9<\/a>.<\/p>\n\n\n\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12559498\/\">Estudios<\/a> La evaluaci\u00f3n del efecto de este tratamiento en la EM muestra una mejora de la discapacidad. Las resonancias magn\u00e9ticas tambi\u00e9n indican una mejora en el n\u00famero y el tama\u00f1o de las lesiones cerebrales.<\/p>\n\n\n\n<p>La eficacia m\u00e1s notable de la IgIV se evidencia en las menores tasas de reca\u00edda despu\u00e9s del parto. En otras enfermedades desmielinizantes autoinmunes como <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0165572815000764\">NMO<\/a>La IgIV redujo la tasa de reca\u00edda de 0,1 a 0,006 en un a\u00f1o.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-side-effects-of-ivig\"><span class=\"ez-toc-section\" id=\"Side_Effects_of_IVIG\"><\/span>Efectos secundarios de la IgIV<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Mientras recibe IgIV para la EM, podr\u00eda experimentar temporalmente los siguientes efectos secundarios:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Fiebre<\/li>\n\n\n\n<li>Erupciones<\/li>\n\n\n\n<li>N\u00e1useas<\/li>\n\n\n\n<li>Dolor de cabeza<\/li>\n\n\n\n<li>S\u00edntomas parecidos a los de la gripe<\/li>\n<\/ul>\n\n\n\n<p>Menos del 1% de los receptores podr\u00edan experimentar el <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/ivig-long-term-side-effects\/\">efectos secundarios a largo plazo de la IgIV<\/a>, incluido:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Insuficiencia renal (de los ri\u00f1ones)<\/li>\n\n\n\n<li>Eventos tromb\u00f3ticos (coagulaci\u00f3n)<\/li>\n\n\n\n<li>Meningitis as\u00e9ptica<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-ivig-treatment-for-ms-go\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Treatment_for_MS_Go\"><\/span>\u00bfC\u00f3mo va el tratamiento con IgIV para la EM?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Puede recibir tratamiento con IgIV en un centro ambulatorio u optar por <a href=\"https:\/\/ameripharmaspecialty.com\/es\/home-infusion\/\">infusiones caseras<\/a>Es un procedimiento sencillo en el que una enfermera capacitada administra la soluci\u00f3n por v\u00eda subcut\u00e1nea o intravenosa.<\/p>\n\n\n\n<p>Recibir IgIV para la EM tomar\u00e1 de 1 a 4 horas cada vez. El proceso no es doloroso, pero podr\u00eda sentir molestias cuando la enfermera le inserte la aguja en el brazo.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-long-does-ivig-take-to-work\"><span class=\"ez-toc-section\" id=\"How_Long_Does_IVIG_Take_to_Work\"><\/span>\u00bfCu\u00e1nto tiempo tarda en hacer efecto la IgIV?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-1024x682.jpg\" alt=\"A woman receiving IV treatment\" class=\"wp-image-23258\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-1024x682.jpg 1024w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-768x511.jpg 768w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-1536x1022.jpg 1536w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-280x186.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-370x246.jpg 370w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-960x639.jpg 960w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1-1280x852.jpg 1280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-receiving-iv-treatment-1.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p><\/p>\n\n\n\n<p>Podr\u00edan pasar varios d\u00edas o semanas hasta que note alguna mejor\u00eda en los s\u00edntomas de la EM. Los cambios m\u00e1s significativos se producir\u00e1n unos meses despu\u00e9s de iniciar el tratamiento.<\/p>\n\n\n\n<p>Por lo tanto, es fundamental tener paciencia y no esperar resultados de la noche a la ma\u00f1ana.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-much-does-ivig-for-ms-cost\"><span class=\"ez-toc-section\" id=\"How_Much_Does_IVIG_for_MS_Cost\"><\/span>\u00bfCu\u00e1nto cuesta la IgIV para la EM?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/cost-of-ivig-treatment\/\">El costo de la IgIV<\/a> El tratamiento de la EM var\u00eda seg\u00fan la persona. Depende de los siguientes factores:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Edad<\/li>\n\n\n\n<li>Peso<\/li>\n\n\n\n<li>M\u00e9todo de inyecci\u00f3n<\/li>\n\n\n\n<li>Duraci\u00f3n del tratamiento<\/li>\n\n\n\n<li>El n\u00famero de dosis necesarias<\/li>\n<\/ul>\n\n\n\n<p>Dependiendo de la marca, cada gramo de IgIV puede costar entre $100 y $350.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-insurance-and-financial-aid-for-ivig\"><span class=\"ez-toc-section\" id=\"Insurance_and_Financial_Aid_for_IVIG\"><\/span>Seguro y ayuda financiera para la IgIV<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>El seguro generalmente cubre una parte del costo del tratamiento dependiendo del diagn\u00f3stico de la persona y si un m\u00e9dico lo considera necesario.<\/p>\n\n\n\n<p>Aun as\u00ed, los tratamientos con IgIV pueden ser costosos. Puedes reducir los costos revisando <a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">asistencia para copagos<\/a> programas que ofrecen asistencia financiera para su condici\u00f3n.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-receive-at-home-ivig-for-ms-from-ameripharma-specialty-pharmacy\"><span class=\"ez-toc-section\" id=\"Receive_At-Home_IVIG_for_MS_from_AmeriPharma%C2%AE_Specialty_Pharmacy\"><\/span>Reciba IgIV en casa para la EM de la farmacia especializada AmeriPharma\u00ae<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La IgIV es un tratamiento prometedor para la esclerosis m\u00faltiple y puede simplificar la vida con esta enfermedad. Puede recibir infusiones de IgIV c\u00f3modamente a trav\u00e9s de enfermeras capacitadas en la Farmacia Especializada AmeriPharma\u00ae.<\/p>\n\n\n\n<p>Ofrecemos servicios de infusi\u00f3n a domicilio y medicamentos dif\u00edciles de conseguir para <a href=\"https:\/\/ameripharmaspecialty.com\/es\/conditions-treatments\/\">varias condiciones<\/a> Para ayudarle a gestionar su salud. Con coordinaci\u00f3n integral de servicios, asistencia con copagos y asistencia 24\/7\/365 en m\u00e1s de 40 estados y territorios de EE. UU., nos esforzamos por simplificar su tratamiento. <a href=\"https:\/\/ameripharmaspecialty.com\/es\/get-started\/\">Habla con un especialista<\/a> Hoy para comenzar a recibir IgIV para la EM.<\/p>","protected":false},"excerpt":{"rendered":"<p>La esclerosis m\u00faltiple (EM) es una enfermedad debilitante que afecta a casi un mill\u00f3n de estadounidenses. Los tratamientos para la EM sol\u00edan centrarse \u00fanicamente en la prevenci\u00f3n de complicaciones. Sin embargo, gracias a avances significativos en la medicina, como el uso de inmunoglobulina intravenosa (IVIG) para la EM, los pacientes ahora disfrutan de una mejor calidad de vida.<\/p>","protected":false},"author":27,"featured_media":23086,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[33],"class_list":["post-23085","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-samantha-kaeberlein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A Guide to IVIG Therapy for MS | AmeriPharma\u2122 Specialty<\/title>\n<meta name=\"description\" content=\"Looking for information on IVIG therapy for multiple sclerosis (MS)? Learn about IVIG treatment for MS in this comprehensive guide from AmeriPharma\u2122 Specialty.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Guide to IVIG Therapy for MS | AmeriPharma\u2122 Specialty\" \/>\n<meta property=\"og:description\" content=\"Looking for information on IVIG therapy for multiple sclerosis (MS)? Learn about IVIG treatment for MS in this comprehensive guide from AmeriPharma\u2122 Specialty.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-20T20:39:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-04T22:31:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Samantha Kaeberlein, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/\"},\"author\":{\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\"},\"headline\":\"A Comprehensive Guide to IVIG Therapy for MS\",\"datePublished\":\"2023-07-20T20:39:20+00:00\",\"dateModified\":\"2025-06-04T22:31:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/\"},\"wordCount\":1629,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/ivig-for-ms-woman-wheelchair-scaled-1.jpg\",\"keywords\":[\"Dr. Samantha Kaeberlein\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/\",\"name\":\"A Guide to IVIG Therapy for MS | AmeriPharma\u2122 Specialty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/ivig-for-ms-woman-wheelchair-scaled-1.jpg\",\"datePublished\":\"2023-07-20T20:39:20+00:00\",\"dateModified\":\"2025-06-04T22:31:26+00:00\",\"description\":\"Looking for information on IVIG therapy for multiple sclerosis (MS)? Learn about IVIG treatment for MS in this comprehensive guide from AmeriPharma\u2122 Specialty.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/ivig-for-ms-woman-wheelchair-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/ivig-for-ms-woman-wheelchair-scaled-1.jpg\",\"width\":2560,\"height\":1706,\"caption\":\"Woman with MS sitting in a wheelchair\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/ivig\\\/a-comprehensive-guide-to-ivig-therapy-for-ms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Comprehensive Guide to IVIG Therapy for MS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/#\\\/schema\\\/person\\\/aa941bb470287e10309b2fe7f5b15430\",\"name\":\"Dr. Samantha Kaeberlein, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g\",\"caption\":\"Dr. Samantha Kaeberlein, PharmD\"},\"description\":\"Dr. Samantha Kaeberlein, PharmD was born and raised in Canton, OH. She received her pharmacy degree from Northeast Ohio Medical University (NEOMED) in 2020. The most rewarding part of her job is providing medical guidance so patients can make informed, well-rounded decisions regarding their healthcare. Her areas of expertise are geriatrics and long-term care. In her free time, she enjoys spending time outdoors, reading, and hunting for the best cup of coffee in America.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/samantha\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gu\u00eda para la terapia con inmunoglobulina intravenosa (IVIG) para la esclerosis m\u00faltiple | AmeriPharma\u2122 Especialidad","description":"\u00bfBusca informaci\u00f3n sobre la terapia con inmunoglobulina intravenosa (IVIG) para la esclerosis m\u00faltiple (EM)? Conozca el tratamiento con IVIG para la EM en esta gu\u00eda completa de AmeriPharma\u2122 Specialty.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/","og_locale":"es_MX","og_type":"article","og_title":"A Guide to IVIG Therapy for MS | AmeriPharma\u2122 Specialty","og_description":"Looking for information on IVIG therapy for multiple sclerosis (MS)? Learn about IVIG treatment for MS in this comprehensive guide from AmeriPharma\u2122 Specialty.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-07-20T20:39:20+00:00","article_modified_time":"2025-06-04T22:31:26+00:00","og_image":[{"width":2560,"height":1706,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg","type":"image\/jpeg"}],"author":"Dr. Samantha Kaeberlein, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Samantha Kaeberlein, PharmD","Est. reading time":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/"},"author":{"name":"Dr. Samantha Kaeberlein, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430"},"headline":"A Comprehensive Guide to IVIG Therapy for MS","datePublished":"2023-07-20T20:39:20+00:00","dateModified":"2025-06-04T22:31:26+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/"},"wordCount":1629,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg","keywords":["Dr. Samantha Kaeberlein"],"articleSection":["IVIG"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/","url":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/","name":"Gu\u00eda para la terapia con inmunoglobulina intravenosa (IVIG) para la esclerosis m\u00faltiple | AmeriPharma\u2122 Especialidad","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg","datePublished":"2023-07-20T20:39:20+00:00","dateModified":"2025-06-04T22:31:26+00:00","description":"\u00bfBusca informaci\u00f3n sobre la terapia con inmunoglobulina intravenosa (IVIG) para la esclerosis m\u00faltiple (EM)? Conozca el tratamiento con IVIG para la EM en esta gu\u00eda completa de AmeriPharma\u2122 Specialty.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg","width":2560,"height":1706,"caption":"Woman with MS sitting in a wheelchair"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/vi\/ivig\/a-comprehensive-guide-to-ivig-therapy-for-ms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/es\/"},{"@type":"ListItem","position":2,"name":"A Comprehensive Guide to IVIG Therapy for MS"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/es\/#website","url":"https:\/\/ameripharmaspecialty.com\/es\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/es\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/es\/#\/schema\/person\/aa941bb470287e10309b2fe7f5b15430","name":"Dra. Samantha Kaeberlein, PharmD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fabe5720eac93901a4790d5e25493a8cf2fdf076c21466237b10de4cc181b9d2?s=96&d=mm&r=g","caption":"Dr. Samantha Kaeberlein, PharmD"},"description":"La Dra. Samantha Kaeberlein, PharmD, naci\u00f3 y creci\u00f3 en Canton, Ohio. Obtuvo su t\u00edtulo en farmacia en la Universidad M\u00e9dica del Noreste de Ohio (NEOMED) en 2020. Lo m\u00e1s gratificante de su trabajo es brindar orientaci\u00f3n m\u00e9dica para que los pacientes puedan tomar decisiones informadas y completas sobre su atenci\u00f3n m\u00e9dica. Sus \u00e1reas de especializaci\u00f3n son la geriatr\u00eda y los cuidados a largo plazo. En su tiempo libre, disfruta de pasar tiempo al aire libre, leer y encontrar el mejor caf\u00e9 de Estados Unidos.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg",2560,1706,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-1536x1024.jpg",1536,1024,true],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-2048x1365.jpg",2048,1365,true],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-1280x853.jpg",1280,853,true]},"uagb_author_info":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"uagb_comment_info":0,"uagb_excerpt":"Multiple sclerosis (MS) is a debilitating condition affecting nearly one million Americans. Treatments for MS used to focus only on preventing complications. However, with significant advancements in medicine, like using IVIG for MS, patients are now enjoying a better quality of life.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg",2560,1706,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg",2560,1706,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg",2560,1706,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-1536x1024.jpg",1536,1024,true],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-2048x1365.jpg",2048,1365,true],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/07\/ivig-for-ms-woman-wheelchair-scaled-1-1280x853.jpg",1280,853,true]},"rttpg_author":{"display_name":"Dr. Samantha Kaeberlein, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/samantha\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"Multiple sclerosis (MS) is a debilitating condition affecting nearly one million Americans. Treatments for MS used to focus only on preventing complications. However, with significant advancements in medicine, like using IVIG for MS, patients are now enjoying a better quality of life.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23085"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23085\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23086"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23085"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}